Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice

Journal of Neuroimmunology

Volumn 261, Issue 1-2, 2013, Pages 53-59

  Martín García, Elena ^a   Mannara, Francesco ^b   Gutiérrez Cuesta, Javier ^a   Sabater, Lidia ^b   Dalmau, Josep ^b,c,d   Maldonado, Rafael ^a   Graus, Francesc ^b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Intrathecal injection; Lambert Eaton Myasthenic syndrome; Mouse model; P Q type voltage gated calcium channel antibodies; Paraneoplastic cerebellar degeneration; Small cell lung cancer

Indexed keywords

CALCIUM CHANNEL P TYPE ANTIBODY; CALCIUM CHANNEL Q TYPE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CONTROLLED STUDY; EATON LAMBERT SYNDROME; EMBRYO; FETUS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LOCOMOTION; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY;

INTRATHECAL INJECTION; LAMBERT-EATON MYASTHENIC SYNDROME; MOUSE MODEL; P/Q-TYPE VOLTAGE-GATED CALCIUM CHANNEL ANTIBODIES; PARANEOPLASTIC CEREBELLAR DEGENERATION; SMALL-CELL LUNG CANCER;

ANIMALS; AUTOANTIBODIES; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CEREBELLAR ATAXIA; HEK293 CELLS; HUMANS; INJECTIONS, SPINAL; MICE; PARANEOPLASTIC CEREBELLAR DEGENERATION; RATS;

EID: 84881023418     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.05.003     Document Type: Article

References (32)

1. Becker E.B., Zuliani L., Pettingill R., Lang B., Waters P., Dulneva A., Sobott F., Wardle M., Graus F., Bataller L., Robertson N.P., Vincent A. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 2012, 83:437-440.
2. Bernal F., Graus F., Pifarre A., Saiz A., Benyahia B., Ribalta T. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol. 2002, 103:509-515.
3. Black J.L. The voltage-gated calcium channel gamma subunits: a review of the literature. J. Bioenerg. Biomembr. 2003, 35:649-660.
4. Blumenfeld A.M., Recht L.D., Chad D.A., DeGirolami U., Griffin T., Jaeckle K.A. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology 1991, 41:1682-1685.
5. Boronat A., Sabater L., Saiz A., Dalmau J., Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 2011, 76:795-800.
6. Carpentier A.F., Rosenfeld M.R., Delattre J.Y., Whalen R.G., Posner J.B., Dalmau J. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin. Cancer Res. 1998, 4:2819-2824.
7. Clouston P.D., Saper C.B., Arbizu T., Johnston I., Lang B., Newsom-Davis J., Posner J.B. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992, 42:1944-1950.
8. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., Dessain S.K., Rosenfeld M.R., Balice-Gordon R., Lynch D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7:1091-1098.
9. Darnell R.B., Posner J.B. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 2003, 349:1543-1554.
10. Filliol D., Ghozland S., Chluba J., Martin M., Matthes H.W., Simonin F., Befort K., Gaveriaux-Ruff C., Dierich A., LeMeur M., Valverde O., Maldonado R., Kieffer B.L. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat. Genet. 2000, 25:195-200.
11. Fukuda T., Motomura M., Nakao Y., Shiraishi H., Yoshimura T., Iwanaga K., Tsujihata M., Eguchi K. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann. Neurol. 2003, 53:21-28.
12. Goldstein J.M., Waxman S.G., Vollmer T.L., Lang B., Johnston I., Newsom-Davis J. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects. J. Neurol. Neurosurg. Psychiatry 1994, 57:1138-1139.
13. Graus F., Illa I., Agusti M., Ribalta T., Cruz-Sanchez F., Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J. Neurol. Sci. 1991, 82-87.
14. Graus F., Lang B., Pozo-Rosich P., Saiz A., Casamitjana R., Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002, 59:764-766.
15. Graus F., Delattre J.Y., Antoine J.C., Dalmau J., Giometto B., Grisold W., Honnorat J., Smitt P.S., Vedeler C., Verschuuren J.J., Vincent A., Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 2004, 75:1135-1140.
16. Ishida K., Mitoma H., Wada Y., Oka T., Shibahara J., Saito Y., Murayama S., Mizusawa H. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 2007, 78:190-192.
17. Komai K., Iwasa K., Takamori M. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. J. Neurol. Sci. 1999, 166:126-130.
18. Lalonde R., Strazielle C. The effects of cerebellar damage on maze learning in animals. Cerebellum 2003, 2:300-309.
19. Liao Y.J., Safa P., Chen Y.R., Sobel R.A., Boyden E.S., Tsien R.W. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2705-2710.
20. Ludwig A., Flockerzi V., Hofmann F. Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. J. Neurosci. 1997, 17:1339-1349.
21. Mason W.P., Graus F., Lang B., Honnorat J., Delattre J.Y., Valldeoriola F., Antoine J.C., Rosenblum M.K., Rosenfeld M.R., Newsom-Davis J., Posner J.B., Dalmau J. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997, 120:1279-1300.
22. Monstad S.E., Drivsholm L., Storstein A., Aarseth J.H., Haugen M., Lang B., Vincent A., Vedeler C.A. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J. Clin. Oncol. 2004, 22:795-800.
23. Mori Y., Friedrich T., Kim M.S., Mikami A., Nakai J., Ruth P., Bosse E., Hofmann F., Flockerzi V., Furuichi T. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 1991, 350:398-402.
24. Parsons K.T., Kwok W.W. Linear B-cell epitopes in Lambert-Eaton myasthenic syndrome defined by cell-free synthetic peptide binding. J. Neuroimmunol. 2002, 126:190-195.
25. Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R., Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 2009, 12:1152-1158.
26. Sabater L., Titulaer M., Saiz A., Verschuuren J., Gure A.O., Graus F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 2008, 70:924-928.
27. Sabater L., Hoftberger R., Boronat A., Saiz A., Dalmau J., Graus F. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS One 2013, 8:e60438.
28. Saiz A., Blanco Y., Sabater L., Gonzalez F., Bataller L., Casamitjana R., Ramio-Torrenta L., Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
29. Shams'ili S., Grefkens J., de Leeuw B., van den Bent M., Hooijkaas H., van der Holt B., Vecht C., Sillevis Smitt P. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003, 126:1409-1418.
30. Sillevis Smitt P., Kinoshita A., De Leeuw B., Moll W., Coesmans M., Jaarsma D., Henzen-Logmans S., Vecht C., De Zeeuw C., Sekiyama N., Nakanishi S., Shigemoto R. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N. Engl. J. Med. 2000, 342:21-27.
31. Stoodley C.J. The cerebellum and cognition: evidence from functional imaging studies. Cerebellum 2012, 11:352-365.
32. Takamori M., Iwasa K., Komai K. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Neurology 1997, 48:1261-1265.